MedPath
NMPA Approval

Bivalirudin for Injection

国药准字H20223462

June 30, 2022

Drug Information

注射用比伐芦定

注射剂

0.25g(按C₉₈H₁₃₈N₂₄O₃₃计)

化学药品

June 30, 2022

Company Information

Applicant Company

泰州市扬子江南路1号

Manufacturing Company

江苏省泰州市扬子江南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用比伐芦定 - NMPA 批准文号 | MedPath